RNS Number : 1679I
Caledonia Mining Corporation PLC
12 May 2025
 

 

Caledonia Mining Corporation Plc

Strong Q1 Performance Driven by Increased Production and Higher Gold Prices

 

·     

·     

·     

·     

·     

·     

·     

·     

·     

·     

·     

·     

·     

·     

·     

·      [1]

·   

[1] Refer to the technical report entitled "NI 43-101 Technical Report on the Blanket Gold Mine, Zimbabwe" with effective date December 31, 2023 prepared by Caledonia Mining Corporation Plc and filed by the Company on SEDAR+ (https://www.sedarplus.ca) on May 15, 2024.

 

Craig James Harvey, MGSSA, MAIG, Caledonia Vice President, Technical Services, has reviewed and approved the scientific and technical information contained in this news release. Craig James Harvey is a "Qualified Person" as defined by each of (i) the Canadian Securities Administrators' National Instrument 43-101 - Standards of Disclosure for Mineral Projects and (ii) sub-part 1300 of Regulation S-K of the U.S. Securities Act.





·     

·     

·     

 

 

When: May 12, 2025 at 2:00pm London time

Topic: Q1 2025 Results Call for Investors

Register in advance for this webinar:

 

Enquiries:

Caledonia Mining Corporation Plc

Mark Learmonth

Camilla Horsfall

 

Tel: +44 1534 679 800

Tel: +44 7817 841 793

Cavendish Capital Markets Limited (Nomad and Joint Broker)

Adrian Hadden

Pearl Kellie

 

 

Tel: +44 207 397 1965

Tel: +44 131 220 9775

Liberum Panmure (Joint Broker)

Scott Mathieson

Ailsa MacMaster

 

Tel: +44 20 3100 2000

Camarco, Financial PR/ IR (UK)

Gordon Poole

Elfie Kent

Fergus Young

 

Tel: +44 20 3757 4980

3PPB (Financial PR, North America)

Patrick Chidley

Paul Durham

 

Tel: +1 917 991 7701

Tel: +1 203 940 2538

Curate Public Relations (Zimbabwe)

Debra Tatenda

 

Tel: +263 77802131

IH Securities (Private) Limited (VFEX Sponsor - Zimbabwe)

Lloyd Mlotshwa

 

 

Tel:

 

 

 

 

 

 

This announcement contains inside information which is disclosed in accordance with the Mrket Abuse Regulation (EU) No. 596/2014 ("MAR") as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

Cautionary Note Concerning Forward-Looking Information

Information and statements contained in this news release that are not historical facts are "forward-looking information" within the meaning of applicable securities legislation that involve risks and uncertainties relating, but not limited to Caledonia's current expectations, intentions, plans, and beliefs.  Forward-looking information can often be identified by forward-looking words such as "anticipate", "believe", "expect", "goal", "plan", "target", "intend", "estimate", "could", "should", "may" and "will" or the negative of these terms or similar words suggesting future outcomes, or other expectations, beliefs, plans, objectives, assumptions, intentions or statements about future events or performance. Examples of forward-looking information in this news release include: production guidance, our plans and timing regarding further exploration and drilling and development, future costs, the development of Bilboes and Motapa, the amount and funding of capital costs and the publication of the Bilboes feasibility study.  This forward-looking information is based, in part, on assumptions and factors that may change or prove to be incorrect, thus causing actual results, performance or achievements to be materially different from those expressed or implied by forward-looking information.  Such factors and assumptions include, but are not limited to: failure to establish estimated resources and reserves, the grade and recovery of ore which is mined varying from estimates, success of future exploration and drilling programs, reliability of drilling, sampling and assay data, assumptions regarding the representativeness of mineralization being inaccurate, success of planned metallurgical test-work, capital and operating costs varying significantly from estimates, delays in obtaining or failures to obtain required governmental, environmental or other project approvals, inflation, changes in exchange rates, fluctuations in commodity prices, delays in the development of projects and other factors.

 

Security holders, potential security holders and other prospective investors should be aware that these statements are subject to known and unknown risks, uncertainties and other factors that could cause actual results to differ materially from those suggested by the forward-looking statements.  Such factors include, but are not limited to: risks relating to estimates of mineral reserves and mineral resources proving to be inaccurate, fluctuations in gold price, risks and hazards associated with the business of mineral exploration, development and mining, risks relating to the credit worthiness or financial condition of suppliers, refiners and other parties with whom the Company does business; inadequate insurance, or inability to obtain insurance, to cover these risks and hazards, employee relations; relationships with and claims by local communities and indigenous populations; political risk; risks related to natural disasters, terrorism, civil unrest, public health concerns (including health epidemics or outbreaks of communicable diseases such as the coronavirus (COVID-19)); availability and increasing costs associated with mining inputs and labour; the speculative nature of mineral exploration and development, including the risks of obtaining or maintaining necessary licenses and permits, diminishing quantities or grades of mineral reserves as mining occurs; global financial condition, the actual results of current exploration activities, changes to conclusions of economic evaluations, and changes in project parameters to deal with unanticipated economic or other factors, risks of increased capital and operating costs, environmental, safety or regulatory risks, expropriation, the Company's title to properties including ownership thereof, increased competition in the mining industry for properties, equipment, qualified personnel and their costs, risks relating to the uncertainty of timing of events including targeted production rate increase and currency fluctuations, risks related to potentially being unable to remedy the deficiency in control over accounting for deferred tax liabilities and risks related to potentially being unable to prevent financial statements misstatements in the future.  Security holders, potential security holders and other prospective investors are cautioned not to place undue reliance on forward-looking information.  By its nature, forward-looking information involves numerous assumptions, inherent risks and uncertainties, both general and specific, that contribute to the possibility that the predictions, forecasts, projections and various future events will not occur.  Caledonia undertakes no obligation to update publicly or otherwise revise any forward-looking information whether as a result of new information, future events or other such factors which affect this information, except as required by law.

This news release is not an offer of the shares of Caledonia for sale in the United States or elsewhere. This news release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of the shares of Caledonia, in any province, state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such province, state or jurisdiction.

 

 

Condensed Consolidated Statements of profit or loss and Other comprehensive income (Unaudited)

($'000's)

 

3 months ended March 31,

 

 

2025

2024

2023




Restated*

Restated*

Revenue

 

56,178

38,528

29,435

Royalty

 

     (2,771)

 (1,934)

(1,480)

Production costs

 

   (22,622)

(18,960)

(19,850)

Depreciation

 

(3,859)

 (3,819)

  (2,255)

Gross profit

 

26,926

13,815

5,850

Net foreign exchange (loss) gain

 

(1,252)

(4,882)

36

Administrative expenses

 

(4,598)

(2,611)

(5,938)

Net derivative financial instrument expense

 

(1,592)

(302)

(434)

Equity-settled share-based credit (expense)

 

144

(201)

(110)

Cash-settled share-based expense

 

(158)

(53)

(280)

Other expenses

 

(843)

(600)

(640)

Other income

 

66

164

18

Operating profit (loss)

 

18,693

5,330

(1,498)

Finance income

 

6

6

5

Finance cost

 

(900)

(732)

(772)

Profit (loss) before tax

 

17,799

4,604

(2,265)

Tax expense

 

(6,636)

(2,530)

(2,380)

Profit (loss) for the period

 

11,163

2,074

(4,645)






Other comprehensive income

 

 



Items that are or may be reclassified to profit or loss

 

 



Exchange differences on translation of foreign operations

207

(144)

(369)

Total comprehensive income for the period

 

11,370

1,930

(5,014)






Profit (loss) attributable to:

 

 



Owners of the Company

 

8,915

1,486

 (5,356)

Non-controlling interests

 

2,248

588

711

Profit (loss) for the period

 

11,163

2,074

(4,645)






Total comprehensive income attributable to:

 

 



Owners of the Company

 

9,122

1,342

(5,725)

Non-controlling interests

 

2,248

588

711

Total comprehensive income for the period

 

11,370

1,930

(5,014)






Earnings (loss) per share (cents)

 

 



Basic earnings (loss) per share

 

44.6

7.3

(32.2)

Diluted earnings (loss) per share

 

44.6

7.3

(32.2)






Adjusted earnings per share (cents)

 

 



Basic

 

58.5

9.7

(26.3)

Dividends paid per share#

 

-

14.0

14.0

* Refer to section 11 and section 12 of the MD&A.

 # Refer section 3.3.3 of the MD&A.



 

 

 

 

 

 

Summarised Consolidated Statements of Financial Position ($'000's) (Unaudited)

As at

Mar 31

Dec 31

Dec 31


2025

2024

2023

 

 

 

*Restated

Total non-current assets

290,914

287,046

274,074

Income tax receivable

216

355

1,120

Inventories

25,317

23,768

20,304

Derivative financial assets

-

-

88

Trade and other receivables

17,268

12,675

9,952

Prepayments

7,776

6,748

2,538

Cash and cash equivalents

8,728

4,260

6,708

Assets held for sale

13,520

13,512

13,519

Total assets

363,739

348,364

328,303

Total non-current liabilities

71,405

68,505

63,970

Cash-settled share-based payment

674

634

920

Income tax payable

4,363

2,958

10

Lease liabilities

140

95

167

Loans and borrowings

1,455

1,174

-

Loan notes

1,093

855

665

Trade and other payables

28,222

26,647

20,503

Overdrafts

13,300

12,928

17,740

Liabilities associated with assets held for sale

118

104

128

Total liabilities

120,770

113,900

104,103

Total equity

242,969

234,464

224,200

Total equity and liabilities

363,739

348,364

328,303

* Refer to section 11 and section 12 of the MD&A.



 

Condensed Consolidated Statements of Cash Flows  (Unaudited)

 

($'000's)

 


Three months ended

March 31,


2025

2024




Cash inflow from operations

18,709

6,535

Interest received

6

6

Finance costs paid

(543)

(573)

Tax paid

(4,831)

(1,081)

Net cash inflow from operating activities

13,341

4,887




Cash flows used in investing activities



Acquisition of property, plant and equipment

(7,250)

(3,741)

Acquisition of exploration and evaluation assets

(1,229)

(430)

Acquisition of Put options

(1,592)

(240)

Net cash used in investing activities

(10,071)

(4,411)




Cash flows from financing activities



Dividends paid

(1,387)

(2,720)

Payment of lease liabilities

(181)

(37)

Loan notes - solar bond issue receipts (net of transaction cost)

2,387

-

Net cash from / (used in) financing activities

819

(2,757)




Net increase / (decrease) in cash and cash equivalents

4,089

(2,281)

Effect of exchange rate fluctuations on cash and cash equivalents

7

(847)

Net cash and cash equivalents at the beginning of the period

(8,668)

(11,032)

Net cash and cash equivalents at the end of the period

(4,572)

(14,160)

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
QRFFLFIREFILLIE